Clinical Trials Logo

Clinical Trial Summary

This is a multicenter, double-blind, randomized, vehicle-controlled, parallel-group proof-of-concept study designed to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of topically applied ESR-114 following twice daily (BID) application for 42 days (6 weeks).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03630939
Study type Interventional
Source Escalier Biosciences B.V.
Contact
Status Completed
Phase Phase 1/Phase 2
Start date August 9, 2018
Completion date June 12, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05144165 - Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines
Active, not recruiting NCT04911751 - A Study to Investigate Efficacy and Safety of KBL697 in Patients With Moderate Plaque Type Psoriasis Phase 2
Recruiting NCT02999776 - Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis Phase 1
Recruiting NCT04099979 - A Pilot Study to Explore the Role of Gut Flora in Psoriasis
Completed NCT03726489 - Light Treatment Effectiveness (LITE) Study N/A